RUDRA PANGENI, BSPS, MSPS, PHD
Assistant Professor of Pharmaceutical Sciences
Dr. Rudra Pangeni earned his bachelor's degree in Pharmaceutical Sciences from Pokhara University, Nepal, his master's degree in Pharmaceutical Sciences (Pharmaceutics) from Jamia Hamdard University, India, and his doctoral degree in Pharmaceutics from Mokpo National University, South Korea. He completed postdoctoral training in the Nanotherapeutics Lab in the Department of Pharmaceutics at Virginia Commonwealth University (VCU) School of Pharmacy, where he later joined the faculty as a Research Assistant Professor.
His research has been recognized through multiple federal and institutional research awards. He is an inventor on more than five pending patent applications or awarded patents. Dr. Pangeni has also authored numerous peer-reviewed publications, review articles, and book chapters in leading journals. Dr. Pangeni is an active mentor, collaborator, and invited speaker dedicated to advancing pharmaceutical sciences while training the next generation of scientists.
Education
- PhD, Pharmaceutics, Mokpo National University, South Korea, 2015-2019
- Master's of Pharmaceutical Sciences, Pharmaceutics, Jamia Hamdard University, India, 2012-2014
- Bachelor's of Pharmaceutical Sciences, School of Health and Allied Sciences, Pokhara University, Nepal, 2007-2011
Postdoctoral Training
- Postdoctoral Fellow, Department of Pharmaceutics, Virginia Commonwealth University, USA, 2021-2023
- Postdoctoral Fellow, School of Pharmacy, Mokpo National University, South Korea, 2019-2020
Research
Dr. Pangeni specializes in the design and optimization of advanced drug delivery systems to overcome biological barriers and enhance therapeutic outcomes. His research focuses on formulation strategies for ocular, pulmonary, oncologic, topical, and neuropathic pain disorders, with an emphasis on translating innovative formulations into clinically meaningful therapies.
Publications
Research Papers
(*Co-first author)
Pangeni R, Mannangatti P, Kaffash E, Gunawardena M, Mukhopadhyay ND, Mochel MC, Das SK, Xu Q, Fisher PB. IVMT-Rx-3 microemulsion as low-dose metronomic chemotherapy for melanoma metastasis. Cells. 2026; 15(13):1178.
Maji S, Kumar A, Mannangatti P, Modi J, Gunawardena M, LoPresti MQ, Mukhopadhyay ND, Brown AM, Pangeni R, Xu Q, et al. MDA-9/Syntenin small molecule inhibitor IVMT-Rx-4 blocks prostate cancer bone metastasis. Pharmacological Research. 2026; 227:108164.
Gunawardena M, Chau B, Nothacker H, et al. Machine learning guided optimization of an oral microemulsion system: A Bayesian optimization approach. AAPS Open. 2026; 12:34.
Kaffash E, Pangeni R*, Liang W, Poudel S, Zhao L, Ma J, Xu Q. Fenofibrate microemulsion eyedrops for treating nitrogen mustard-induced corneal injury. Journal of Controlled Release. 2026.
Pangeni R, Poudel S, Herz SM, Berkbigler G, Duerfeldt AS, Damaj MI, Xu Q. New PPARα agonist A190-loaded microemulsion for chemotherapy-induced peripheral neuropathy. Molecular Pharmaceutics. 2025; 22(3):1641–1656.
Pangeni R, Poudel S, Momin MAM, Farkas D, Dalton C, Hall F, Kang DJ, Hylemon P, Longest W, Hindle M, Xu Q. Inhalable tobramycin EEG powder formulation for treating Pseudomonas aeruginosa-induced lung infection. International Journal of Pharmaceutics. 2024; 662: 124504.
Pangeni R, Hassan AAM, Farkas D, Sudarjat H, Longest W, Hindle M, Xu Q. New air-jet dry powder insufflator for high-efficiency aerosol delivery to rats. Molecular Pharmaceutics. 2023; 20(4); 2207-2216.
Pangeni R, Laxman S, Jha SK, Choi JU, Kweon S, Kang SH, Chang KY, Choi YK, Byun Y, Park JW. Improvement of oral absorption and anticancer efficacy of oxaliplatin-loaded solid formulation: Pharmacokinetic properties in rats and nonhuman primates and the effects of oral metronomic dosing on colorectal cancer. International Journal of Nanomedicine. 2020 9;15:7719-7743.
Lee BC, Pangeni R*, Na J, Koo K, Park JW. Preparation and in vivo evaluation of a highly skin- and nail-permeable efinaconazole topical formulation for enhanced treatment of onychomycosis. Drug Delivery. 2019; 26:1167–1177.
Pangeni R, Jha SK, Maharjan R, Choi JU, Chang KY, Choi YK, Byun Y, Park JW. Intestinal transport mechanism and in vivo anticancer efficacy of a solid oral formulation incorporating an ion-pairing complex of pemetrexed with deoxycholic acid derivatives. International Journal of Nanomedicine. 2019; 14:6339–6356.
Jee JP*, Pangeni R*, Jha SK, Byun Y, Park JW. Preparation and in vivo evaluation of a topical hydrogel system incorporating highly skin-permeable growth factors, quercetin, and oxygen carriers for enhanced diabetic wound-healing therapy. International Journal of Nanomedicine. 2019; 15:5449–5475.
Pangeni R, Panthi VK, Yoon IS, Park JW. Preparation, characterization, and in vivo evaluation of an oral multiple nanoemulsive system for co-delivery of pemetrexed and quercetin. Pharmaceutics. 2018; 10(3):1–22.
Pangeni R, Choi JU, Panthi VK, Byun Y, Park JW. Enhanced oral absorption of pemetrexed by ion-pairing complex formation with deoxycholic acid derivative and multiple nanoemulsion formulations: preparation, characterization, and in vivo oral bioavailability and anticancer effect. International Journal of Nanomedicine. 2018; 13:3329–3351.
Pangeni R, Kang S-W, Oak M, Park EY, Park JW. Oral delivery of quercetin in oil-in-water nanoemulsion: In vitro characterization and in vivo anti-obesity efficacy in mice. Journal of Functional Foods. 2017; 38:571–581.
Pangeni R, Choi SW, Jeon OC, Byun Y, Park JW. Multiple nanoemulsion system for an oral combinational delivery of oxaliplatin and 5-fluorouracil: preparation and in vivo evaluation. International Journal of Nanomedicine. 2016; 11:6379–6399.
Pangeni R, Sharma S, Mustafa G, Ali J, Baboota S. Vitamin E loaded resveratrol nanoemulsion for brain targeting for the treatment of Parkinson's disease by reducing oxidative stress. Nanotechnology. 2014; 25(48):1–13.
Pangeni R, Ali J, Mustafa G, Sharma S, Baboota S. Design expert-supported development and validation of stability indicating high-performance liquid chromatography (HPLC) method for determination of resveratrol in bulk drug and pharmaceutical formulations. International Journal of Pharmaceutical Sciences and Research. 2015; 6(12):5115–5125.
Poudel S, Pangeni R, Huo Z, Farkas D, Gulec S, Zhang Q, Lasaosa M, Tong R, Moeller FG, Li Q, Wang Y, Qin B, Halquist MS, Xu Q. A systematic approach to develop and characterize a compositionally equivalent buprenorphine in situ forming implant (Sublocade®). Journal of Controlled Release. 2026 Mar 4;393: 114793.
Poudel S, Qin C, Pangeni R, Hu Z, Berkbigler G, Gunawardena M, Duerfeldt AS, Xu Q. Oral pharmacokinetic evaluation of a microemulsion-based delivery system for novel A190 prodrugs. Biomolecules. 2025; 15: 1101.
Sudarjat H, Qin C, Ingabire D, Raynold AAM, Pangeni R, Pearcy A, Meng T, Zhao L, Arriaha M, Chow WN, Puetzer JL, Lu X, Moeller FG, Halquist MS, O’Keeffe C, Banks ML, Xu Q. Janus LAAM-loaded electrospun fibrous buccal fils for treating opioid use disorder. Biomaterials. 2025; 317: 123041.
Ingabire D, Qin C, Meng T, Raynold AAM, Sudarjat H, Townsend EA, Pangeni R, Poudel S, Arriaga M, Zhao L, Chow WN, Banks M, Xu Q. Nor-LAAM loaded PLGA microparticles for treating opioid use disorder. Journal of Controlled Release. 2024; 373: 93-104.
Poudel S, Kaffash E, Zhao L, Pangeni R, Chow WN, Xu Q. Dexamethasone sodium phosphate loaded nanoparticles for prevention of nitrogen mustard induced corneal injury. Experimental Eye Research. 2024; 243: 109902.
Zhang Y, Li S, Loch K, Duncan GA, Kaler L, Pangeni R, Peng W, Wang S, Gong X, Xu Q. pH-responsive mucus-penetrating nanoparticles for enhanced cellular interlization by local administration in vaginal tissue. ACS Macro Letters. 2023; 12(4): 446-453.
Maharjan R, Choi JU, Kweon S, Pangeni R, Lee NK, Park SJ, Chang KY, Park JW, Byun Y. A novel oral metronomic chemotherapy provokes tumor-specific immunity resulting in colon cancer eradication in combination with anti-PD-1 therapy. Biomaterials. 2022; 281: 121331.
Maharjan R, Subedi L, Pangeni R, Jha SK, Kang SH, Chang KY, Byun Y, Choi JU, Park JW. Metronomic delivery of orally available pemetrexed-incorporated colloidal dispersions for boosting tumor-specific immunity. Drug Delivery. 2021; 28910: 2313-2328.
Panthi VK, Jha SK, Chaubey R, Pangeni R. Formulation and development of Serratiopeptidase enteric coated tablets and analytical method validation by UV Spectroscopy. International Journal of Analytical Chemistry. 2021.
Jha SK, Chung JY, Pangeni R, Choi HS, Subedi L, Kweon S, Choi JU, Byun Y, Kim YH, Park JW. Enhanced antitumor efficacy of bile acid-lipid complex-anchored docetaxel nanoemulsion via oral metronomic scheduling. Journal of Controlled Release. 2020; 328: 368-394.
Jha SK, Han HS, Subedi L, Pangeni R, Chung JY, Kweon S, Choi JU, Byun Y, Kim YH, Park JW. Enhanced oral bioavailability of an etoposide multiple nanoemulsion incorporating a deoxycholic acid derivative–lipid complex. Drug Delivery. 2020; 27(1): 1501-1513.
Subedi L, Song SY, Jha SK, Lee SH, Pangeni R, Koo KT, Kim BN, Cho SS, Park JW. Preparation of Topical Itraconazole with Enhanced Skin/Nail Permeability and In Vivo Antifungal Efficacy against Superficial Mycosis. Pharmaceutics. 2021; 13(5):622.
Kang KW, Pangeni R, Park JW, Lee J, Yi E. Selective loss of calretinin-poor cochlear afferent nerve fibers in streptozotocin-induced hyperglycemic mice. Journal of Nanoscience and Nanotechnology. 2020; 20(9):5515–5519.
Choi JU, Maharjan R, Pangeni R, Jha SK, Lee NK, Kweon S, Lee HK, Chang KY, Choi YK, Park JW, Byun Y. Modulating tumor immunity by metronomic dosing of oxaliplatin incorporated in multiple oral nanoemulsion. Journal of Controlled Release. 2020; 322:13–30.
Maharjan R, Pangeni R, Jha SK, Choi JU, Chang KY, Choi YK, Park JW, Byun Y. Anti-angiogenic effect of orally available pemetrexed for metronomic chemotherapy. Pharmaceutics. 2019; 11(332):1–22.
Shankar S, Pangeni R, Park JW, Rhim J-W. Preparation of sulfur nanoparticles and their antibacterial activity and cytotoxic effect. Materials Science and Engineering: C. 2018; 92:508–517.
Park DE, Adhikari D, Pangeni R, Panthi VK, Kim HJ, Park JW. Preparation and characterization of callus extract from Pyrus pyrifolia and investigation of its effects on skin regeneration. Cosmetics. 2018; 5(4):1–25.
Choi SW, Pangeni R, Jung DH, Kim SJ, Park JW. Construction and characterization of cell-penetrating peptide-fused fibroblast growth factor and vascular endothelial growth factor for an enhanced percutaneous delivery system. Journal of Nanoscience and Nanotechnology. 2018; 18(2):842–847.
Choi SW, Pangeni R, Park JW. Nanoemulsion-based hydrogel for topical delivery of highly skin-permeable growth factor combinations: Preparation and in vitro evaluation. Journal of Nanoscience and Nanotechnology. 2017; 17(4):2363–2369.
Choi JU, Lee SW, Pangeni R, Byun Y, Yoon IS, Park JW. Preparation and in vivo evaluation of cationic elastic liposomes comprising highly skin-permeable growth factors combined with hyaluronic acid for enhanced diabetic wound-healing therapy. Acta Biomaterialia. 2017; 57:197–215.
Adhikari D, Panthi VK, Pangeni R, Kim HJ, Park JW. Preparation, characterization, and biological activities of topical anti-aging ingredients in a Citrus junos callus extract. Molecules. 2017; 22(12)1–15.
Panth N, Paudel KR, Sharma K, Pangeni R, Karki B, Pradhan M. Formulation, in vitro evaluation and optimization of GI floating tablet of ranitidine HCl. World Journal of Pharmacy and Pharmaceutical Sciences. 2013.3(1):1–13.
Review Papers
Pangeni R, Meng T, Poudel S, Sharma D, Hutsell H, Ma J, Rubin BK, Longest W, Hindle M, Xu Q. Airway mucus in pulmonary diseases: Muco-adhesive and muco-penetrating particles to overcome the airway mucus barriers. International Journal of Pharmaceutics. 2023; 634: 122661.
Pangeni R, Sahni JK, Ali J, Sharma S, Baboota S. Resveratrol: review on therapeutic potential and recent advances in drug delivery. Expert Opinion on Drug Delivery. 2014; 11(8):1285–1298.
Pangeni R, Kang S, Jha SK, Subedi L, Park JW. Intestinal membrane transporter-mediated approaches to improve oral drug delivery. Journal of Pharmaceutical Investigation. 2021; 51: 137–158.
Imran M, Jha LA, Hasan N, Shrestha J, Pangeni R, Parvez N, Mohammed Y, Jha SK, Paudel KR. Nanodecoys-Future of drug delivery by encapsulating nanoparticles in natural cell membranes. International Journal of Pharmaceutics. 2022; 621: 121790.
Book Chapters
Paudel KR, Panth N, Pangeni R, Awasthi R, Chawla V, Mehta M, Tambuwala MM, Hansbro PM. Targeting lung cancer using advanced drug delivery systems. Elsevier Academic Press. Chapter 23; 493–509.
Pangeni R, Xu Q, Rubin B. Gardenhire 11e: Rau's Respiratory Care Pharmacology, Chapter 9: Mucus-Controlling Drug Therapy. Submitted for new edition 2022.
Patents
Xu Q, Pangeni R, Dale Farkas, Poudel S, Adapter for In Vitro Release Testing of Long-Acting Injectables, Method of Manufacture Thereof, and Method of Use Thereof,” VCU XU-25-086F, (INVENTION), Aug 20, 2025.
Xu Q, Pangeni R, Hsu K, Lowrey P, Murtagh O. Liposome compositions of DAGLB inhibitors and their methods of use thereof. Patent pending, UT Tech ID # 8476 HSU, Filed on 07/22/2024.
Xu Q, Pangeni R, Poudel S. Damaj I, Duerfeldt AS. PPARα agonist loaded microemulsion for oral delivery: compositions and methods of use thereof. Patent pending, 63/706,994, Filed on 10/14/2024.
Xu Q, Pangeni R, Das SK, Fisher PB. MDA-9 single and dual PDZ domain targeted inhibitors loaded microemulsion compositions and methods of use thereof. Patent pending, FIS-24-085F, Filed on 10/04/2024.
Xu Q, Pangeni R, Kaffash E, Liang W, Ma J. Novel PPARα agonist loaded microemulsion compositions and methods of use thereof. Patent pending, 63544460, Filed on 11/18/2023.
Training
- Training in Neurotherapeutics Discovery and Development for Academic Scientists 2022 -Supported by the National Institute of Neurological Disorders and Stroke (NINDS) at UC Davis Conference Center, California.
Projects
High dose acetaminophen with fomepizole and n-acetylcysteine rescue for treatment
of advanced malignancies
Pangeni R (PI)
McGuire VA Medical Center
10/1/2024 - 9/30/2025
In Vitro and In Vivo Assessment of Buprenorphine Extended Release Injections for Generic
Product Equivalence
Pangeni R (Co-I)
FDA
09/21/23 – 9/20/26
Fenofibrate microemulsion for treating nitrogen mustard-induced corneal injury
Pangeni R (Co-I)
NIH/NEI
9/15/2025- 5/31/2030
Meeting Abstracts
Pangeni R, Schweizer R, Poudel S, Farkas DR, Momin M, Hall F, Chow WN, Kang J, Hylemon P, Longest P, Hindle M, Xu Q, Tobramycin-Synthetic Lung Surfactant Dry Powder for Treatment of Pseudomonas aeruginosa-Induced Lung Infection in Rats, Respiratory Drug Delivery 2026. Volume 2, 351-355. LINK
Ehsan Kaffash, Wentao Liang, Rudra Pangeni, Sagun Poudel, Jian-Xing (Jay) Ma, Qingguo Xu; Fenofibrate Loaded Microemulsion for Improving Diabetic Corneal Wound Healing. Invest. Ophthalmol. Vis. Sci. 2026;67(7):2113. LINK
Poudel S, Pangeni R, Momin M, Farkas DR, Kang J, Hylemon P, Longest P, Xu Q, Hindle M, PEGylated Ciprofloxacin Liposomal Dry Powder: Efficacy in Acute Rat Pseudomonas aeruginosa-Induced Lung Infection Respiratory Drug Delivery 2026. Volume 2, 356-360. LINK
Qingguo Xu, Ehsan Kaffash, Rudra Pangeni, Wentao Liang, Sagun Poudel, Jian-xing Ma Ma; A new microemulsion eye drop for treating nitrogen mustard-induced corneal injury. Invest. Ophthalmol. Vis. Sci. 2026;67(7):2945. LINK
Pangeni R, Momin M, Poudel S, Farkas DR, Hassan A, Longest P, Hindle M, Xu Q, In Vivo Deposition and Retention of Ciprofloxacin Liposomal Dry Powder Aerosol Respiratory Drug Delivery 2025. Volume 2, 304-307. LINK
Hindle M, Farkas DR, DiBlasi RM, Momin M, KenKnight H, Hall F, Dalton CJ, Xu Q, Pangeni R, Aladwani G, Strickler S, Longest P, It’s All About Delivery: Pre-Clinical Development of a Surfactant Powder Aerosol Product Respiratory Drug Delivery 2025. Volume 1, 1-7. LINK
Sally Ong, Joanne Konstantopoulos, Ryan G. Phillips, Rudra Pangeni, Qingguo Xu, Jian-Xing (Jay) Ma, Rebecca M Sappington; Intranasally Administered Nanoparticles Reach the Retina and Choroid in Mice. Invest. Ophthalmol. Vis. Sci. 2025;66(8):4642. LINK
Pangeni R, Hassan A, Farkas DR, Sudarjat H, Longest P, Hindle M, Xu Q, Efficient Delivery of Powder Aerosol to the Lungs of Small Animals with a New Air-Jet Dry Powder Insufflator Respiratory Drug Delivery 2024. Volume 1, 540-543. LINK
Momin M, Farkas DR, Pangeni R, Hassan A, Dalton CJ, Poudel S, Hall F, Xu Q, Longest P, Hindle M, A Novel Air-Jet Dry Powder Insufflator for High Efficiency Aerosol Delivery to Small Animals RDD Asia 2024. Volume 1, 46-53. LINK
Sagun Poudel, Ehsan Kaffash, Divya Bande, Rudra Pangeni, Long Zhao, Qingguo Xu; Dexamethasone sodium phosphate loaded polymeric nanoparticles for treating nitrogen mustard induced corneal injury. Invest. Ophthalmol. Vis. Sci. 2024;65(7):3660. LINK
Poudel S, Pangeni R, Momin M, Hassan A, Farkas DR, Dalton CJ, Kang J, Hylemon P, Longest P, Hindle M, Xu Q, In Vivo Efficacy of Tobramycin Excipient Enhanced Growth Dry Powder Aerosol in Pseudomonas aeruginosa Lung Infection Model Respiratory Drug Delivery 2024. Volume 1, 544-547. LINK
Pangeni R, Hassan A, Loch K, Sudarjat H, Meng T, Momin M, Longest P, Hindle M, Xu Q, Liposomal Dry Powder Aerosol Formulation of Ciprofloxacin: Effect of Sucrose and Mannitol on Aerosol Performance Respiratory Drug Delivery 2022. 533-536. LINK
Xu Q, Hassan A, Meng T, Pangeni R, Rubin BK, Longest P, Hindle M, Dry Powder Aerosol Containing Muco-Inert Particles for Pulmonary Drug Delivery Respiratory Drug Delivery 2022. 537-540. LINK
Presentations/Talks
Poudel S, Pangeni R, Momin M, Farkas DR, Kang J, Hylemon P, Longest P, Xu Q, Hindle M, PEGylated Ciprofloxacin Liposomal Dry Powder: Efficacy in Acute Rat Pseudomonas aeruginosa Induced Lung Infection, Respiratory Drug Delivery (May 10, 2026), Volume 2, 356-360, Phoenix, Arizona, USA.
Han S, Poudel S, Kaffash E, Zhao L, Pangeni R, Xu Q, A long-acting nanoparticle therapy for treating nitrogen mustard-induced corneal injury. Innovations in Countermeasures and Toxicology Research (ICTR) Conference, Jun 1-3, 2026, Chicago, IL.
Gunawardena M, Chau B, Nothacker H, Pangeni R, Roper, T, Xu Q, McGill C, Machine Learning Guided Optimization of an Oral Microemulsion System: A Bayesian Optimization Approach. AI Driven Nanoparticle Design for Drug Delivery Workshop, February 2-6, 2026, Leiden, NLD.
Gunawardena M, Pangeni R, Poudel S, Herz S, Berkbigler G, Duerfeldt A, Damaj M, Xu Q, Non-Opioid PPARα Agonist Loaded Oral Microemulsion for the Treatment of Chemotherapy-Induced Peripheral Neuropathy. Virginia Drug Discovery Consortium Annual Meeting, June 5-6, 2025, Newport News, VA.
Poudel S, Pangeni R, Zhang Q, Wang Y, Qin B, Halquist M S, Xu Q. In vitro release testing system development for buprenorphine in situ forming implant, Controlled Release Society AM & E (July 14, 2025), Philadelphia, USA.
Pangeni R, Poudel S, Momin MAM, Farkas D, Kang J, Hylemon P, Longest PW, Hindle M, Xu Q, Assessing the in vivo efficacy of tobramycin EEG dry powder aerosol in Pseudomonas aeruginosa induced lung infection model, WBC 2024, May, 2024, Daegu, South Korea.
Pangeni R, Hassan A, Farkas D, Sudarjat H, Longest PW, Hindle M, Xu Q, Efficient delivery of powder aerosol to the lungs of small animals with a new air-jet dry powder insufflator, Respiratory Drug Delivery, May 2024, Tucson, AZ.
Pangeni R, Hassan A, Farkas D, Sudarjat H, Longest PW, Hindle M, Xu Q, New air-jet dry powder insufflator for high efficiency aerosol delivery to the lungs of small animals, nanoDDS, September 2023, Boston, MA.
Pangeni R, Hassan A, Loch K, Sudarjat H, Meng T, Momin MAM, Longest PW, Hindle M, Xu Q.Ciprofloxacin liposomes loaded dry powder aerosol: Effect of sucrose and mannitol on aerosol performance. Poster presentation at Virtual Research and Career Day 2022. Received the Research Day Postdoctoral Runner-up Award. March 2022.
Pangeni R, Park JW. Preparation and in vivo evaluation of an oral pemetrexed nanoemulsion. Poster Presentation at the International Convention of The Pharmaceutical Society of Korea. October 2017.
Pangeni R, Choi SW, Park JW. Preparation and in vivo evaluation of an orally available nanoemulsion for combination therapy of oxaliplatin and 5-fluorouracil. Spring International Convention of The Pharmaceutical Society of Korea. April 2016.
Pangeni R, Park JW. Preparation and in vivo evaluation of an oral pemetrexed nanoemulsion. Oral Presentation at the 2017 Fall International Convention of The Pharmaceutical Society of Korea, October 2017.
Kaffash E, Pangeni R, Liang W, Poudel S, Ma J, Xu Q, PPARα Agonist Eye Drop for Healing Nitrogen Mustard-Induced Corneal Injury, Annual Graduate Student Research Symposium, 2024, Virginia Commonwealth University.
Kaffash E, Pangeni R, Liang W, Poudel S, Ma J, Xu Q, PPARα Agonist Eye drop for Healing Nitrogen Mustard-Induced Corneal Injury, Virginia Drug Discovery Consortium, May 2024, Virginia Beach, Virginia.
Poudel S, Pangeni R, Momin MAM, Hassan A, Farkas D, Dalton C, Kang JD, Hylemon P, Longest PW, Hindle M, Xu Q. Inhalable Tobramycin Excipient Enhanced Growth Dry Powder Aerosol in Pseudomonas aeruginosa Induced Lung Infection, VADDC, 2024.
Poudel S, Pangeni R, Momin MAM, Hassan A, Farkas D, Dalton C, Kang JD, Hylemon P, Longest PW, Hindle M, Xu Q. In Vivo Efficacy of Tobramycin EEG Dry Powder Aerosol in Bioluminescent Pseudomonas aeruginosa Induced Lung Infection Model. VCU School of Pharmacy Research and Career Day, 2024.
Poudel S, Pangeni R, Momin MAM, Hassan A, Farkas D, Dalton C, Kang JD, Hylemon P, Longest PW, Hindle M, Xu Q. In Vivo Efficacy of Tobramycin EEG Dry Powder Aerosol in Bioluminescent Pseudomonas aeruginosa Induced Lung Infection Model. VCU Graduate Research Symposium, 2024.
Sudarjat H, Moothedathu Raynold AA, Qin C, Meng T, Pangeni R, Halquist M, Lu X, Moeller G, O’Keeffe C, Xu Q. Novel Electrospun Nanofiber Buccal Films for Treating Opioid Use Disorder. AAPS PharmSci 360, October 2022, Boston, MA.
Sudarjat H, Moothedathu Raynold AA, Qin C, Meng T, Pangeni R, Halquist M, Lu X, Moeller
G, O’Keeffe C, Xu Q. Opioid Use Disorder: Development of electrospun nanofiber buccal
films of LAAM for OUD Treatment. Research and Career Day Symposium. Virginia Commonwealth
University. March 2022, Richmond, Virginia.
Park DE, Pangeni R, Park JW. Highly skin- and nail-permeable Efinaconazole topical
formulation for enhanced treatment of onychomycosis. Poster Presentation at the 2019
International Conference of the Korean Society of Pharmaceutical Sciences and Technology.
November 2019.
Jha SK, Pangeni R, Park JW. Intestinal transport mechanism and enhanced antitumor efficacy of oral metronomic-oxaliplatin-loaded nanoemulsion in combination with pemetrexed and immune checkpoint inhibitor. International Convention of The Pharmaceutical Society of Korea. April, 2019.
Park DE, Pangeni R, Park JW. Preparation and in vivo evaluation of an oral nanoemulsion delivering pemetrexed and quercetin. International Convention of The Pharmaceutical Society of Korea, October 2018.
Choi SW, Pangeni R, Park JW. Preparation and in vivo evaluation of elastic nanoliposomes comprising highly skin-permeable growth factors complexed with hyaluronic acid to enhance chronic wound healing. International Convention of The Pharmaceutical Society of Korea. October 2016.
Memberships
- Controlled Release Society
- American Association of Pharmaceutical Scientists